Triple combination of HAIC-FO plus tyrosine kinase inhibitors and immune checkpoint inhibitors for advanced hepatocellular carcinoma: A systematic review and meta-analysis

BACKGROUND: The triple combination of hepatic arterial infusion chemotherapy (HAIC) with fluorouracil, leucovorin, and oxaliplatin (FOLFOX) plus tyrosine kinase inhibitor (TKI) and immune checkpoint inhibitors (ICIs) is expected to have a synergistic anticancer effect in HCC. We conducted this meta-...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Zhongbao, Zhang, Jian, Xu, Lan, Wang, Huanjing, Mao, Xuequn, Zou, Rong, Wang, Qingqing, Han, Zhuang, Di, Zhenhai, Wu, Daguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578571/
https://www.ncbi.nlm.nih.gov/pubmed/37844117
http://dx.doi.org/10.1371/journal.pone.0290644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578571/
https://www.ncbi.nlm.nih.gov/pubmed/37844117
http://dx.doi.org/10.1371/journal.pone.0290644

Ejemplares similares